MRI with contrast for metastatic colon cancer liver lesions
Part of Cancer, Digestive system clinical trials.
This trial studies an MRI technique using a contrast dye (gadopetate/gadolinium) to better look at liver lesions that may be colon cancer spread. It may help doctors more accurately assess which liver tumors are present and guide next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have biopsy-proven colon (colorectal) cancer
- You have had imaging that suggests spots in the liver may be cancer spread
- You can safely have an MRI and follow the study schedule for its full duration
- You do not have metal/implants or other objects that are not safe for MRI
- Your kidney function is not severely reduced (eGFR is 30 or higher)
- You are not pregnant and have liver function that is not severely impaired
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of MRI scans to see if one is as good as the other for finding and tracking liver tumors in people with colorectal cancer. You can join if you are starting chemotherapy or need your cancer checked.
This trial studies how well MRI can evaluate liver metastases (spread to the liver) from colorectal cancer. If you have measurable liver lesions, your MRI results may help doctors better track and plan care.
This study uses a special MRI scan to see how colorectal cancer in the liver responds to planned chemotherapy before and after surgery. It may help doctors better measure treatment success and plan care.
This trial tests whether a newer contrast agent, gadopiclenol, works as well as the standard one for liver scans. It might be an option if you need an MRI to check for liver disease, tumors, or treatment response.
This study uses a special MRI to look at liver metastases from colorectal cancer, aiming to see how well the MRI can see the tumors and how they respond to chemotherapy. If you qualify, you'll have an extra MRI before starting chemotherapy, which might help doctors understand the cancer better.
This trial uses MRI scans to study how colorectal cancer that has spread to the liver grows. It may help doctors choose better treatments.
Hear when a new Liver Metastasis Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.